SCHRODER INVESTMENT MANAGEMENT GROUP - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$9,510,653
+9.1%
9,600,000
+11.6%
0.01%
+7.7%
Q2 2023$8,715,155
+16.1%
8,600,000
+18.6%
0.01%
+18.2%
Q1 2023$7,504,910
+214.2%
7,250,000
+229.5%
0.01%
+175.0%
Q4 2022$2,388,408
+9.3%
2,200,0000.0%0.00%0.0%
Q3 2022$2,185,000
-0.0%
2,200,0000.0%0.00%
+33.3%
Q2 2022$2,186,000
-2.0%
2,200,0000.0%0.00%0.0%
Q1 2022$2,231,0002,200,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 55,306,226$54,866,5182.72%
MACKAY SHIELDS LLC 76,286,000$74,883,9012.06%
Sonora Investment Management Group, LLC 10,890,000$10,840,0750.93%
ADVENT CAPITAL MANAGEMENT /DE/ 39,812,000$39,636,8270.92%
BANQUE PICTET & CIE SA 636,000$63,228,5450.75%
PIER 88 INVESTMENT PARTNERS LLC 1,902,000$1,884,6160.47%
LOOMIS SAYLES & CO L P 2,074,551$183,5570.32%
Liberty Mutual Group Asset Management Inc. 1,025,000$1,0150.28%
iA Global Asset Management Inc. 14,690,000$14,6250.24%
RATIONAL ADVISORS LLC 1,803,000$1,786,0520.16%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders